Clinical spectrum of impulse control disorders in Parkinson’s disease

Weintraub, Daniel, David, Anthony S., Evans, Andrew H., Grant, Jon E., Stacy, Mark·2015·Movement Disorders

DOI 10.1002/mds.26016

Cited by (311)

Items 101–200 of 311

Can we predict development of impulsive–compulsive behaviours in Parkinson’s disease?
Lucia Ricciardi, Christian Lambert, Rosa De Micco, Francesca Morgante, Mark John Edwards · 2017 · Journal of Neurology Neurosurgery & Psychiatry
White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
Mahtab Mojtahed Zadeh, Amir Ashraf‐Ganjouei, Farzaneh Ghazi Sherbaf, Maryam Haghshomar, Mohammad Hadi Aarabi · 2018 · Frontiers in Neurology
Impulse Control Disorders and Dopamine-Related Creativity: Pathogenesis and Mechanism, Short Review, and Hypothesis
Pedro Ruiz · 2018 · Frontiers in Neurology
How close are we to individualized medicine for Parkinson’s disease?
Hee Jin Kim, Beomseok Jeon · 2016 · Expert Review of Neurotherapeutics
Chronic administration of the dopamine D2/3 agonist ropinirole invigorates performance of a rodent slot machine task, potentially indicative of less distractible or compulsive-like gambling behaviour
Paul J. Cocker, M Tremblay, Sukhbir Kaur, Catharine A. Winstanley · 2016 · Psychopharmacology
Hallmarks of Treatment Aspects: Parkinson's Disease Throughout Centuries Including l -Dopa
Hee J. Kim, Beom S. Jeon, Peter G. Jenner · 2017 · International review of neurobiology
Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease
Haritz Jiménez‐Urbieta, Belén Gago, Ana Quiroga‐Varela, Tatiana Rodríguez-Chinchilla, Leyre Merino-Galán, Amaia Oregi, Arantzazu Belloso-Iguerategui, Manuel Delgado‐Alvarado, Irene Navalpotro‐Gómez, Concepció Marı́n et al. · 2018 · Neurobiology of Aging
Clinical characteristics of impulse control and related disorders in Chinese Parkinson’s disease patients
Yu Zhang, An qi He, Lin Li, Wei Chen, Zhen guo Liu · 2017 · BMC Neurology
White matter tract alterations in Parkinson's disease patients with punding
Elisa Canu, Federica Agosta, Vladana Marković, Igor N. Petrović, Iva Stanković, Francesca Imperiale, Tanja Stojković, Massimiliano Copetti, Vladimir Kostić, Massimo Filippi · 2017 · Parkinsonism & Related Disorders
Neurobiological correlates of emotional processing in Parkinson's disease: A systematic review of experimental studies
Anja J.H. Moonen, A.A. Wijers, Kathy Dujardin, Albert F.G. Leentjens · 2017 · Journal of Psychosomatic Research
Disruption of Multiple Distinctive Neural Networks Associated With Impulse Control Disorder in Parkinson's Disease
Pavel Filip, Pavla Linhartová, Pavlína Hlavatá, Rastislav Šumec, Marek Baláž, Martin Bareš, Tomáš Kašpárek · 2018 · Frontiers in Human Neuroscience
Ropinirole, a dopamine agonist with high D3 affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adults
Vishal Rawji, Lorenzo Rocchi, Thomas Foltynie, John C. Rothwell, Marjan Jahanshahi · 2020 · Neuropharmacology
Initial drug treatment in Parkinson’s disease:
Sharon Muzerengi, Carl E Clarke · 2015 · BMJ
Treating the Motor Symptoms of Parkinson Disease
John C. Morgan, Susan Helen Fox · 2016 · CONTINUUM Lifelong Learning in Neurology
Misperceptions and Parkinson's disease
Joseph H. Friedman · 2017 · Journal of the Neurological Sciences
Gambling behavior in Parkinson's Disease: Impulsivity, reward mechanism and cortical brain oscillations
Michela Balconi, Laura Angioletti, Chiara Siri, Nicoletta Meucci, Gianni Pezzoli · 2018 · Psychiatry Research
Compulsive eating behaviors in Parkinson’s disease
I. de Chazeron, Franck Durif, Isabelle Chéreau, Maria Livia Fantini, Ana Marquès, Philippe Derost, Bérengère Debilly, Georges Brousse, Yves Boirie‌, Pierre‐Michel Llorca · 2019 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
Impulsivity trait in the early symptomatic BACHD transgenic rat model of Huntington disease
Giuseppe Manfré, Valérie Doyère, Simon Bossi, Olaf Rieß, Huu Phuc Nguyen, Nicole El Massioui · 2015 · Behavioural Brain Research
Functional imaging studies of Impulse Control Disorders in Parkinson’s disease need a stronger neurocognitive footing
Garance M. Meyer, Charlotte Spay, Chloé Laurencin, Bénédicte Ballanger, Guillaume Sescousse, Philippe Boulinguez · 2019 · Neuroscience & Biobehavioral Reviews
Creativity related to dopaminergic treatment: A multicenter study
Pedro Ruiz, Juan Carlos Martínez‐Castrillo, Lydia Vela · 2019 · Parkinsonism & Related Disorders
Neural correlates of impulse control behaviors in Parkinson’s disease: Analysis of multimodal imaging data
Hamzah Hamid Baagil, Christian Hohenfeld, Ute Habel, Simon Bodo Eickhoff, Raquel E. Gur, Kathrin Reetz, Imis Dogan · 2023 · NeuroImage Clinical
Constitutive depletion of brain serotonin differentially affects rats’ social and cognitive abilities
Lucille Alonso, Polina Peeva, Sabrina Stasko, Michael Bäder, Natalia V. Alenina, York Winter, Marion Rivalan · 2023 · iScience
Association between REM sleep behavior disorder and impulsive–compulsive behaviors in Parkinson’s disease: a systematic review and meta-analysis of observational studies
Haitao Lu, Qiuyan Shen, Quanzhen Zhao, Hongyan Huang, Pingping Ning, Hui Wang, Dan Xie, Yanming Xu · 2019 · Journal of Neurology
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
Michele Fusaroli, Stefano Polizzi, Luca Menestrina, Valentina Giunchi, Luca Pellegrini, Emanuel Raschi, Daniel A. Weintraub, Maurizio Recanatini, Gastone Castellani, Fabrizio De Ponti et al. · 2024 · Drug Safety
Modulating risky decision‐making in Parkinson's disease by transcranial direct current stimulation
Alberto Benussi, Antonella Alberici, Valentina Cantoni, Rosa Manenti, Michela Brambilla, Valentina Dell’Era, Stefano Gazzina, Marta Antonia Manes, Viviana Cristillo, Alessandro Padovani et al. · 2017 · European Journal of Neurology
Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease
Nicole El Massioui, Charlotte Lamirault, Sara Yagüe, Najia Adjeroud, Daniel Garces, Alexis Maillard, Lucille Tallot, Libo Yu-Taeger, Olaf Rieß, Philippe Allain et al. · 2016 · Frontiers in Behavioral Neuroscience
Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications
Pilar Hernandez‐Con, Iris Lin, Eugenia Mamikonyan, Wissam Deeb, Robert Feldman, Andrew D. Althouse, Ryan Barmore, Robert Stephen Eisinger, Meredith Spindler, Michael S. Okun et al. · 2023 · Movement Disorders Clinical Practice
Chemical neuromodulation of cognitive control avoidance
Monja I. Froböse, Roshan Cools · 2018 · Current Opinion in Behavioral Sciences
Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort
Silvia Jesús, Miguel Ángel Labrador‐Espinosa, A. D. Adarmes, Carmen Barrio, Juan Carlos Martínez‐Castrillo, Araceli Alonso Cánovas, Pilar Sánchez Alonso, S. Novo Ponte, María G. Alonso Losada, Nuria López-Ariztegui et al. · 2020 · Scientific Reports
Profile of Neuropsychiatric Symptoms in Parkinson’s Disease: Surgical Candidates Compared to Controls
Valérie M J Lamberti, B. Pereira, E. Lhommée, A. Bichon, E. Schmitt, P. Pelissier, A. Kistner, V. Fraix, A. Castrioto, R. Esselink et al. · 2016 · Journal of Parkinson's Disease
Risk factors for impulse control disorders and related behaviors in Parkinson’s disease: secondary analyses of the ICARUS study
Paolo Barone, Angelo Antonini, Paolo Stanzione, Karin Annoni, Mahnaz Asgharnejad, Ubaldo Bonuccelli · 2019 · Journal of Drug Assessment
Impulse control disorders in Parkinson’s disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis
Lenise G. Soileau, Norris C Talbot, Nicholas R. Storey, Noah J Spillers, James V. D’antoni, Peter C. Carr, Connor M. Galardo, Shilpadevi S. Patil, Shahab Ahmadzadeh, Sahar Shekoohi et al. · 2023 · Neurological Sciences
Increased emissions of 50-kHz ultrasonic vocalizations in hemiparkinsonian rats repeatedly treated with dopaminomimetic drugs: A potential preclinical model for studying the affective properties of dopamine replacement therapy in Parkinson's disease
Nicola Simola, Marcello Serra, Jacopo Marongiu, Giulia Costa, Micaela Morelli · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Brain Stimulation Techniques in Research and Clinical Practice: A Comprehensive Review of Applications and Therapeutic Potential in Parkinson’s Disease
Ata Jahangir Moshayedi, Tahmineh Mokhtari, Mehran Emadi Andani · 2024 · Brain Sciences
Decision-making under ambiguity and risk and executive functions in Parkinson’s disease patients: A scoping review of the studies investigating the Iowa Gambling Task and the Game of Dice
Laura Colautti, Paola Iannello, Maria Caterina Silveri, Alessandro Antonietti · 2023 · Cognitive Affective & Behavioral Neuroscience
A case–control study investigating food addiction in Parkinson patients
I. de Chazeron, Franck Durif, Céline Lambert, Isabelle Chéreau, Maria Livia Fantini, Ana Marquès, Philippe Derost, Bérengère Debilly, Georges Brousse, Yves Boirie‌ et al. · 2021 · Scientific Reports
Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease
Bo Liu, Wenjing Luo, Yingmin Mo, Chunying Wei, Ran Tao, Han Min · 2019 · Neuroscience Letters
Neurobiology and clinical features of impulse control failure in Parkinson’s disease
Matthieu Béreau, Paul Krack, Norbert Brüggemann, Thomas Frank Münte · 2019 · Neurological Research and Practice
Integrating genetic and clinical data to predict impulse control disorders in Parkinson's disease
Silvia Jesús, María Teresa Periñán, Carmen Cortés, Dolores Buiza‐Rueda, Daniel Macías‐García, A. D. Adarmes, Laura Muñoz‐Delgado, Miguel Ángel Labrador‐Espinosa, Cristina Tejera‐Parrado, Pilar Gómez‐Garre et al. · 2020 · European Journal of Neurology
Altered Food Behavior and Cancer: A Systematic Review of the Literature
Daniele Nucci, Omar Enzo Santangelo, Sandro Provenzano, Mariateresa Nardi, Alberto Firenze, Vincenza Gianfredi · 2022 · International Journal of Environmental Research and Public Health
Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson’s Disease
Xue Qing Yang, Brian Lauzon, Ken N. Seergobin, Penny A. MacDonald · 2018 · Frontiers in Human Neuroscience
Impulse Control Behaviors in Parkinson's Disease: Drugs or Disease? Contribution From Imaging Studies
Rosa De Micco, Antonio Russo, Gioacchino Tedeschi, Alessandro Tessitore · 2018 · Frontiers in Neurology
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease
Sara C. Staubo, Ole‐Martin Fuskevåg, Mathias Toft, Ingeborg Haugesag Lie, Kirsti M. J. Alvik, Pål Jostad, Stein H. Tingvoll, Hallvard Lilleng, Kristina Rosqvist, Elisabet Størset et al. · 2023 · European Journal of Neurology
Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication
Gaetano Salomone, Massimo Marano, Lazzaro di Biase, Jean-Marc Melgari, Vincenzo Di Lazzaro · 2015 · Parkinsonism & Related Disorders
Risky decision-making and affective features of impulse control disorders in Parkinson’s disease
Alice Martini, Simon J. Ellis, James A. Grange, Stefano Tamburin, Denise Dal Lago, Greta Vianello, Nicola M.J. Edelstyn · 2017 · Journal of Neural Transmission
The elevated gradient of aversion: a new apparatus to study the rat behavior dimensions of anxiety, fear, and impulsivity
Javier Leonardo Rico, R. Bonuti, Sílvio Morato · 2019 · Brazilian Journal of Medical and Biological Research
Modafinil alters decision making based on feedback history – a randomized placebo-controlled double blind study in humans
Christian Bellebaum, Lars Kuchinke, Patrik Roser · 2016 · Journal of Psychopharmacology
Molecular Imaging of Opioid System in Idiopathic Parkinson's Disease
Stéphane Thobois, Christine Brefel‐Courbon, Didier Le Bars, Véronique Sgambato · 2018 · International review of neurobiology
The Impact of Compulsivity and Impulsivity in Cerebellar Ataxia: A Case Series
Nadia Amokrane, Chi-Ying Roy Lin, Natasha A. Desai, Sheng‐Han Kuo · 2020 · Tremor and Other Hyperkinetic Movements
Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study
Yuan‐Pin Lin, Hsing-Yi Liang, Yueh‐Sheng Chen, Cheng‐Hsien Lu, Yih‐Ru Wu, Yung‐Yee Chang, Wei‐Che Lin · 2021 · Journal of NeuroEngineering and Rehabilitation
Genes and Nonmotor Symptoms in Parkinson's Disease
Ee‐Wei Lim, Eng‐King Tan · 2017 · International review of neurobiology
The pharmacological management of the behavioral aspects of Parkinson’s disease: an update
Marta Campagnolo, Aron Emmi, Roberta Biundo, Eleonora Fiorenzato, Lucia Batzu, К. Ray Chaudhuri, Angelo Antonini · 2023 · Expert Opinion on Pharmacotherapy
Reviving: restoring depression-like behaviour through glial cell–derived neurotrophic factor treatment in the medial prefrontal cortex
Yehao Liu, Xiaoyu Zhou, Ke Xue, Ruiao Sun, Yan Tang, Chuanxi Tang · 2024 · Journal of Psychiatry and Neuroscience
Impulse control disorders in Parkinson’s disease: What’s new?
Ana Marquès, Simon J.G. Lewis · 2025 · Journal of Neurology
Age at Parkinson's disease onset modulates the effect of levodopa on response inhibition: Support for the dopamine overdose hypothesis from the antisaccade task
Josefine Waldthaler, Lena Stock, Charlotte Krüger‐Zechlin, Lars Timmermann · 2021 · Neuropsychologia
Personality Traits and Cortical Activity Affect Gambling Behavior in Parkinson’s Disease
Michela Balconi, Chiara Siri, Nicoletta Meucci, Gianni Pezzoli, Laura Angioletti · 2018 · Journal of Parkinson s Disease
Parkinson’s disease management and impulse control disorders: current state and future perspectives
Carmine Vitale, Marianna Amboni, Roberto Erro, Marina Picillo, Maria Teresa Pellecchia, Paolo Barone, Luigi Trojano, Gabriella Santangelo · 2019 · Expert Review of Neurotherapeutics
Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics
Ankur Butala, Melissa D. Shepard, Gregory M. Pontone · 2019 · Handbook of clinical neurology
MRI of Motor and Nonmotor Therapy‐Induced Complications in Parkinson's Disease
Giulia Donzuso, Federica Agosta, Elisa Canu, Massimo Filippi · 2020 · Movement Disorders
Amphetamine-induced dopamine release and impulsivity in Parkinson’s disease
Alexander K. Song, Kaitlyn R. Hay, Paula Trujillo, Megan A. Aumann, Adam J. Stark, Yan Yan, Hakmook Kang, Manus Joseph Donahue, David Harold Zald, Daniel O. Claassen · 2021 · Brain
Neuropsychiatric Issues in Parkinson Disease
Jennifer G. Goldman · 2016 · CONTINUUM Lifelong Learning in Neurology
Association between Baseline Cognitive Score and Postoperative Delirium in Parkinson’s Disease Patients following Deep Brain Stimulation Surgery
Yongde Zhou, Ting Fan, Yu Ma, Jian Hua Ding, Jianfeng Yu, Yao Chen, Cuiping Yu, Rongsong Zhou, Baoguo Wang, Chengmei Shi · 2022 · Parkinson s Disease
Impulse control disorders, dopamine dysregulation syndrome and sex dysfunction in Parkinson's disease
Laura Irincu, Irina Ivan, Ștefania Diaconu, Cristian Falup‐Pecurariu · 2022 · International review of neurobiology
Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy
Rong Ye, Frank Hubert Hezemans, Claire O’Callaghan, Kamen A. Tsvetanov, Catarina Rua, Peter Simon Jones, Negin Holland, Maura Malpetti, Alexander G. Murley, Roger A. Barker et al. · 2023 · Journal of Neuroscience
Introduction to Parkinson disease (PD) and its complications
Markéta Marvanová · 2016 · Mental Health Clinician
Neurocognitive correlates of medication-induced addictive behaviours in Parkinson's disease: A systematic review
Andrew Dawson, Nadeeka N. Dissanayaka, Andrew H. Evans, Antonio Verdejo‐García, Trevor T.‐J. Chong, Giuseppe Frazzitta, Davide Ferrazzoli, Paola Ortelli, Murat Yücel, Adrian Carter · 2018 · European Neuropsychopharmacology
Special issue “Parkinson’s disease”
Heiko Braak, Kelly Del Tredici-Braak, Thomas Gasser · 2018 · Cell and Tissue Research
Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited
Chloé Laurencin, Téodor Danaila, Emmanuel Broussolle, Stéphane Thobois · 2016 · Revue Neurologique
The β‐adrenoceptor blocker propranolol ameliorates compulsive‐like gambling behaviour in a rodent slot machine task: implications for iatrogenic gambling disorder
Paul J. Cocker, Min-Ya Lin, M. Tremblay, Sukhbir Kaur, Catherine A. Winstanley · 2018 · European Journal of Neuroscience
Sleep in Parkinson’s Disease with Impulse Control Disorder
Michela Figorilli, Patrizia Congiu, Rosamaria Lecca, Gioia Gioi, Roberto Frau, Monica Puligheddu · 2018 · Current Neurology and Neuroscience Reports
Cognitive and behavioral assessment in Parkinson’s disease
Saül Martínez‐Horta, Andrea Horta‐Barba, Jaime Kulisevsky · 2019 · Expert Review of Neurotherapeutics
Linking brain activity during sequential gambling to impulse control in Parkinson's disease
Brian Numelin Haagensen, Damian Marc Herz, David Meder, Kristoffer Hougaard Madsen, Annemette Løkkegaard, Hartwig Roman Siebner · 2020 · NeuroImage Clinical
Pathological Gambling in Parkinson's disease: Autonomic measures supporting impaired decision‐making
Laura Angioletti, Chiara Siri, Nicoletta Meucci, Gianni Pezzoli, Michela Balconi · 2018 · European Journal of Neuroscience
Impulse Control Disorders in REM Sleep Behavior Disorder
Maria Livia Fantini, Franck Durif, Ana Marquès · 2019 · Current Treatment Options in Neurology
Involvement of dopamine D3 receptor in impulsive choice decision-making in male rats
Hui Shen, Zilu Ma, Emma Hans, Ying Duan, Guo‐Hua Bi, Yurim C. Chae, Alessandro Bonifazi, Francisco O. Battiti, Amy Hauck Newman, Zheng‐Xiong Xi et al. · 2024 · Neuropharmacology
Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats
Haritz Jiménez‐Urbieta, Belén Gago, Ana Quiroga‐Varela, Tatiana Rodríguez-Chinchilla, Leyre Merino-Galán, Manuel Delgado‐Alvarado, Irene Navalpotro‐Gómez, Arantzazu Belloso-Iguerategui, Concepció Marı́n, María Rodríguez‐Oroz · 2020 · Psychopharmacology
Safety considerations when using non-ergot dopamine agonists to treat Parkinson’s disease
Fabrizio Stocchi, Barbara Fossati, Margherita Torti · 2020 · Expert Opinion on Drug Safety
Driving and Parkinson’s Disease: A Survey of the Patient’s Perspective
Peter Brock, Lloyd L. Oates, William K. Gray, Emily J. Henderson, Helen Mann, Victoria Joanna Haunton, Rob Skelly, Annette Hand, Matthew L Davies, Richard W. Walker · 2021 · Journal of Parkinson s Disease
Neuromodulation Approaches in Parkinson’s Disease Using Deep Brain Stimulation and Transcranial Magnetic Stimulation
Ryan T. Cleary, Richard D. Bucholz · 2021 · Journal of Geriatric Psychiatry and Neurology
Dopamine-induced changes to thalamic GABA concentration in impulsive Parkinson disease patients
Paula Trujillo, Alexander K. Song, Kaitlyn R. Hay, Megan A. Aumann, Yan Yan, Hakmook Kang, Manus Joseph Donahue, Daniel O. Claassen · 2022 · npj Parkinson s Disease
Screening for impulse control disorders in Parkinson’s disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors
Manuela Contin, Giovanna Lopane, Luca Marini, Susan Mohamed, Luisa Sambati, Patrizia De Massis, Maria Guarino, Simonetta Sermi, Chiara Persichella, Pietro Cortelli et al. · 2022 · Neurological Sciences
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, A. F. M. Little, Han‐Joon Kim · 2017 · Expert Review of Neurotherapeutics
Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
Xue Qing Yang, Daniel Glizer, Andrew Vo, Ken N. Seergobin, Penny A. MacDonald · 2016 · Frontiers in Human Neuroscience
Is Motor Side Onset of Parkinson's Disease a Risk Factor for Developing Impulsive‐Compulsive Behavior? A Cross‐Sectional Study
Clélie Phillipps, Nadine Longato, Matthieu Béreau, Nicolas Carrière, Ouhaïd Lagha‐Boukbiza, Amaury C. Mengin, Ben Monga, Luc Defebvre, Fabienne Ory‐Magne, Anna Castrioto et al. · 2020 · Movement Disorders
Combined subthalamic and nucleus basalis of Meynert deep brain stimulation for Parkinson’s disease with dementia (DEMPARK-DBS): protocol of a randomized, sham-controlled trial
Christine Daniels, Frank Steigerwald, Philipp Capetian, Cordula Matthies, Uwe Malzahn, Peter Ulrich Heuschmann, Jens Volkmann · 2020 · Neurological Research and Practice
Neural correlates of impulsive compulsive behaviors in Parkinson’s disease: A Japanese retrospective study
Ikko Kimura, Gajanan S. Revankar, Kotaro Ogawa, Kaoru Amano, Yuta Kajiyama, Hideki Mochizuki · 2022 · NeuroImage Clinical
Metacognition deficits and impulsivity in Parkinson’s Disease patients with and without gambling behavior: A pilot study
Laura Angioletti, Salvatore Campanella, Michela Balconi · 2020 · Neurology Psychiatry and Brain Research
Characteristics of behavioural addiction in Parkinson’s disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case–control study
Bernd Leplow, Daniela Renftle, Mareike Rutenkröger, Katja Michaelis, Susanne Solbrig, Walter Maetzler, Daniela Berg, Inga Liepelt‐Scarfone · 2023 · Journal of Neural Transmission
Associations Between Gut Microbiota Composition and Impulse Control Disorders in Parkinson’s Disease
Sheng-Hsuan Lin, Ru-Jen Lin, Chia-Ling Chu, Yan-Lin Chen, Shih-Chen Fu · 2025 · International Journal of Molecular Sciences
Diagnose und Therapie des Parkinsonsyndroms
Heinz Reichmann · 2017 · MMW - Fortschritte der Medizin
Neues zu Diagnostik und Therapie des idiopathischen Parkinson-Syndroms
Josefine Waldthaler, Lars Timmermann · 2019 · Fortschritte der Neurologie · Psychiatrie
Concomitant Othello syndrome and impulse control disorders in a patient with Parkinson’s disease: A case report
Tian Xu, Zhao-Sheng Li, Wei Fang, Lanxiao Cao, Guohua Zhao · 2022 · World Journal of Clinical Cases
Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson’s Disease: What Do Clinical and Neuroimaging Studies Tell Us?
Alexandru Hanganu, Oury Monchi · 2018 · Current Neurology and Neuroscience Reports
Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis
Cheryl S. Hankin, Daniel Lee, Diego Garcı́a-Borreguero, Zhaohui Wang · 2019 · Journal of Clinical Sleep Medicine
Deepening the decisional processes under value-based conditions in patients affected by Parkinson’s disease: A comparative study
Laura Colautti, Paola Iannello, Maria Caterina Silveri, Anna Rıta Gıovagnolı, Antonio Emanuele Elia, Fulvio Pepe, Eugenio Magni, Alessandro Antonietti · 2024 · Cognitive Affective & Behavioral Neuroscience
Highlighting the goals for Parkinson’s care: commentary on NICE Guidelines for Parkinson’s in Adults (NG71)
Peter Brock, James Michael Fisher, Annette Hand, Richard William Walker · 2018 · Age and Ageing
Neural correlates of risky decision making in Parkinson’s disease patients with impulse control disorders
Marit F. L. Ruitenberg, Vincent Koppelmans, Tina Wu, Bruno B. Averbeck, Kelvin L. Chou, Rachael D. Seidler · 2022 · Experimental Brain Research
Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS) in an Italian Parkinson’s disease cohort
Gianpaolo Maggi, Carmine Vitale, Chiara Giacobbe, Angelo Barone, Clara Mastromarino, Federica Iannotta, Marianna Amboni, Daniel A. Weintraub, Gabriella Santangelo · 2024 · Neurological Sciences
Impulsive compulsive behaviours in Parkinson’s disease: patients’ versus caregivers’ perceptions
Lucia Ricciardi, Benedetta Demartini, Massimiliano Pomponi, Diego Ricciardi, Bruno Morabito, Rosaria Renna, Roberto Bernabei, Anna Rita Bentivoglio · 2016 · Journal of Neurology
Deterioration of postural deformity in Parkinson’s disease patients with punding and hobbyism
Ryoma Aoki, Makoto Shiraishi, Kyohei Mikami, Tsutomu Kamo · 2019 · Journal of Clinical Neuroscience